Navigation Links
Nektar Presents Positive Proof-of-Concept Clinical Data for Its New Opioid Molecule, NKTR-181, at American Academy of Pain Medicine's 28th Annual Meeting
Date:2/27/2012

che's PEGASYS® for hepatitis C and Amgen's Neulasta® for neutropenia. Additional development stage products that leverage Nektar's proprietary technology platform include peginesatide, for which Affymax and partner Takeda submitted an new drug application to the United States Food and Drug Administration in May 2011, and Baxter's BAX 855, a long-acting PEGylated rFVIII program which is in Phase 1 clinical development.

Nektar is headquartered in San Francisco, California, with additional R&D operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "expect," "believe," "should," "could," "potential," "may" and similar references to future periods.  Examples of forward-looking statements include our current views as to the potential of NKTR-181 as a new approach to opioid analgesia and pain therapy; the potential of NKTR-181 to exhibit reduced CNS-related side effects associated with standard opioid therapies; our plans to initiate a Phase 2 clinical study for NKTR-181; the value of our polymer conjugate technology platform; and the potential of certain of our other drug candidates and those of our collaboration partners.  Forward-looking statements are neither historical facts nor assurances of future performance.  Instead, they are based only on our current beliefs, expectations, observations and assumptions regarding the potential of our drug candidates and our technology. Because forward-looking statements relate to
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2011 on Wednesday, February 29, 2012, After Close of U.S.-Based Financial Markets
2. Positive Data for Nektars New Mu-Opioid Analgesic Molecule to Treat Acute Pain Highlighted at Neuroscience 2011
3. Nektar Therapeutics Reports Third Quarter 2011 Financial Results
4. Nektar to Announce Financial Results for the Third Quarter of 2011 on Wednesday, November 2, 2011, After Close of U.S.-Based Financial Markets
5. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the UBS 2011 Global Life Sciences Conference in New York City
6. Nektar Initiates Second Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Chronic Pain
7. Nektar Therapeutics Reports Second Quarter 2011 Financial Results
8. Nektar to Announce Financial Results for the Second Quarter of 2011 on Thursday, August 4, 2011, After Close of U.S.-Based Financial Markets
9. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2011 Global Healthcare Conference in New York
10. Nektar Announces New Phase 2 Data for NKTR-102 to Be Presented at 2011 ASCO Annual Meeting
11. FDA Grants Orphan Drug Designation for Nektars Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015  Game-changing ... the latest being the European Commission,s ruling on ... global leader and champion of pharmaceutical supply ... of meeting these mandates and offers several tools ... many countries. From an upcoming webinar in May ...
(Date:4/21/2015)...  IntelliQuit™, the world,s first smartphone breathalyzer for smokers, was selected to present as a finalist ... City on Wednesday April 22.  ... ... ... Thirty percent (30%) of all cardiovascular disease is caused by smoking. ...
(Date:4/21/2015)... , April 21, 2015  The American ... U.S. Food and Drug Administration that the agency,s ... for the last 25 years to protect the ... homeopathic medicines. AAHP, the industry,s trade association, was ... of homeopathic medicines to engage in productive discussions ...
Breaking Medicine Technology:Frequentz Gives the Global Pharmaceutical Supply Chain a Shoulder to Lean On as They Face Expanding Serialization Requirements 2Frequentz Gives the Global Pharmaceutical Supply Chain a Shoulder to Lean On as They Face Expanding Serialization Requirements 3IntelliQuit World's First Smartphone Breathalyzer for Smokers to Present to American Heart Association Innovation Investment Forum 2IntelliQuit World's First Smartphone Breathalyzer for Smokers to Present to American Heart Association Innovation Investment Forum 3Speakers at FDA Hearing Praise Success of Homeopathic Regulatory Framework 2
... CoMeD – On Friday, May 6, 2011, in Tallahassee, ... regulate vaccines containing mercury in Florida.  The amendment would ... import, administer or distribute any vaccine that contained more ... milliliter for children younger than age 7 or pregnant ...
... BEIJING, May 9, 2011 Saladax Biomedical, Inc., a ... to achieve the promise of personalized medicine for new ... Pacific Rim commercialization team to expand its presence in ... Rim commercialization team include: Yunying ...
Cached Medicine Technology:Florida Legislature Refuses to Limit Mercury in Vaccines 2Florida Legislature Refuses to Limit Mercury in Vaccines 3Saladax Biomedical, Inc. Announces Pacific Rim Commercialization Team in Australia and China 2
(Date:4/21/2015)... California (PRWEB) April 21, 2015 On ... Movie Awards” EcoLuxe Lounge at the world famous Avalon ... of sustainable product placement in TV and film, the ... makes appearances at many awards ceremonies and festivals throughout ... top providers of eco-friendly and socially conscious products and ...
(Date:4/21/2015)... Texas (PRWEB) April 21, 2015 ... Sodium Citrate Industry is a professional and in-depth ... Sodium Citrate Market with a focus ... included in the sodium citrate market research are ... Chemicals, Natural Biological, Cofco Biochemical, Capchem, Lianyungang Mupro ...
(Date:4/21/2015)... PA (PRWEB) April 21, 2015 This ... & Related Skin Types, Inc.® (FIRST) will publish a ... The campaign will run throughout the month of May ... It Matters to Someone." The positioning was chosen ... this rare skin disorder and to help support our ...
(Date:4/21/2015)... Further strengthening ties between the two ... donated goods and services to the University of South ... Health BRIDGE Healthcare Clinic. , The BRIDGE clinic – ... eighth year – provides primary medical care to more ... week inside the USF Health Morsani Center for Advanced ...
(Date:4/21/2015)... 21, 2015 Approximately 75 million Americans ... U.S. Environmental Protection Agency (EPA). On top of this, ... smoke increase the level of toxins found in the ... these harmful toxins is to increase consumption of broccoli. ... highest level of glucoraphanin – a long-lasting antioxidant – ...
Breaking Medicine News(10 mins):Health News:Hollywood's Santana Dempsey and Choices Recovery South Bend Examine Victory over Personal Struggles 2Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 2Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 3Health News:May is Ichthyosis Awareness Month. Use Your Voice. 2Health News:USF Health and Florida Hospital Tampa Partner to Expand BRIDGE Clinic 2Health News:USF Health and Florida Hospital Tampa Partner to Expand BRIDGE Clinic 3Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 2Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 3
... ... Healthcare, OAKLAND, Calif., May 1 With talk of a ... poll,this week illustrates that Californians will once again pay particular,attention to ... poll this week by the influential Field Institute released documented,that CNA ...
... of high blood pressure-related deaths occur in poorer ... -- Roughly 80 percent of high blood pressure-related deaths ... study by New Zealand researchers shows. , Once regarded ... pressure is now a global problem that affects both ...
... London, New Delhi, and Singapore (May 2, 2008) SAGE, ... Journal of School Nursing (JOSN) and the NASN Newsletter ... in August 2008., JOSN provides a forum for advancing ... of school nurses, and improving the health of children ...
... AMRIX Growing Rapidly ... Successfully Launched in April, FRAZER, Pa., May 1 ... $433.9 million, compared,to sales of $423.9 million for the first ... million. Basic income per common share for,the quarter was $0.57. ...
... battling illnesses more likely to make up lost slumber ... Older adults with sleep problems, pain, diabetes and respiratory ... day, a U.S. study finds. , Researchers from Vanderbilt ... people, average age 80.1 years, who were monitored for ...
... medical centers in the United States, Canada, Sweden, ... transplanting clusters of insulin-producing islets in adults with ... funded by the National Institutes of Health (NIH), ... islet transplantation lead to improved, long-lasting control of ...
Cached Medicine News:Health News:Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena 2Health News:Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena 3Health News:Hypertension Takes Huge Toll in Developing Countries 2Health News:The National Association of School Nurses selects SAGE to publish its journal 2Health News:Cephalon Reports Strong First Quarter Earnings 2Health News:Cephalon Reports Strong First Quarter Earnings 3Health News:Cephalon Reports Strong First Quarter Earnings 4Health News:Cephalon Reports Strong First Quarter Earnings 5Health News:Cephalon Reports Strong First Quarter Earnings 6Health News:Cephalon Reports Strong First Quarter Earnings 7Health News:Cephalon Reports Strong First Quarter Earnings 8Health News:Cephalon Reports Strong First Quarter Earnings 9Health News:Cephalon Reports Strong First Quarter Earnings 10Health News:Cephalon Reports Strong First Quarter Earnings 11Health News:Cephalon Reports Strong First Quarter Earnings 12Health News:Napping Habits Tied to Sleep Disorders 2Health News:Studies test new approaches to islet transplantation 2Health News:Studies test new approaches to islet transplantation 3Health News:Studies test new approaches to islet transplantation 4
Used for drainage and retrograde pyelogram in pediatric patients. A stiffening stylet is included to aid in catheter placement. Supplied sterile in peel-open packages. Intended for one-time use....
... temporary internal drainage from the ... Supplied sterile in peel-open packages. ... Periodic evaluation is advised; polyurethane, ... not remain indwelling more than ...
... Used for urethral stenting ... drainage following hypospadias repair. ... to be stabilized in ... of sutures at the ...
... temporary internal drainage from ... the bladder. Supplied sterile ... for one-time use. CAUTION: ... C-Flex® and Sof-Flex® stents ...
Medicine Products: